The MET proto-oncogene encodes a membrane MET tyrosine kinase receptor that mainly expressed in epithelial cells, also known as hepatocyte growth factor (HGF) receptors, which have been identified as a tumor driver gene and potential target of NSCLC (9). The gene discussed is MET; the disease is neoplasm.